Basilea Pharmaceutica AG (BSLN) — Financial Flexibility Index
Basilea Pharmaceutica AG (BSLN) has a Financial Flexibility Index of 0.27x as of December 2025. Free cash flow of CHF41.33 Million (operating CF CHF39.03 Million minus capex CHF2.30 Million) represents 0% of total liabilities (CHF154.06 Million). Check asset allocation strategy of Basilea Pharmaceutica AG to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Basilea Pharmaceutica AG Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Basilea Pharmaceutica AG across 24 annual periods. See Basilea Pharmaceutica AG short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Basilea Pharmaceutica AG (2002–2025)
Year-by-year free cash flow to debt coverage for Basilea Pharmaceutica AG. For the full company profile including market capitalisation, see Basilea Pharmaceutica AG (BSLN) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CHF64.71 Million | CHF62.09 Million | CHF154.06 Million | ▼ -2.4% |
| 2024 | 0.43x | CHF76.07 Million | CHF74.36 Million | CHF176.76 Million | ▲ +416.3% |
| 2023 | 0.08x | CHF15.28 Million | CHF14.24 Million | CHF183.29 Million | ▲ +94.4% |
| 2022 | 0.04x | CHF10.36 Million | CHF7.06 Million | CHF241.56 Million | ▲ +142.1% |
| 2021 | -0.10x | CHF-31.16 Million | CHF-32.02 Million | CHF305.87 Million | ▲ +34.8% |
| 2020 | -0.16x | CHF-51.87 Million | CHF-54.13 Million | CHF331.84 Million | ▲ +22.5% |
| 2019 | -0.20x | CHF-63.43 Million | CHF-63.84 Million | CHF314.43 Million | ▲ +10.8% |
| 2018 | -0.23x | CHF-78.79 Million | CHF-79.21 Million | CHF348.44 Million | ▼ -550.1% |
| 2017 | 0.05x | CHF19.73 Million | CHF19.01 Million | CHF392.61 Million | ▲ +124.4% |
| 2016 | -0.21x | CHF-74.61 Million | CHF-75.00 Million | CHF362.76 Million | ▼ -18.2% |
| 2015 | -0.17x | CHF-66.77 Million | CHF-67.78 Million | CHF383.88 Million | ▲ +50.6% |
| 2014 | -0.35x | CHF-70.21 Million | CHF-71.46 Million | CHF199.45 Million | ▼ -38.1% |
| 2013 | -0.26x | CHF-58.37 Million | CHF-59.47 Million | CHF228.88 Million | ▼ -146.0% |
| 2012 | 0.55x | CHF149.50 Million | CHF148.17 Million | CHF269.84 Million | ▲ +158.9% |
| 2011 | -0.94x | CHF-78.85 Million | CHF-82.38 Million | CHF83.82 Million | ▼ -192.7% |
| 2010 | 1.01x | CHF107.88 Million | CHF106.64 Million | CHF106.30 Million | ▲ +198.0% |
| 2009 | -1.04x | CHF-112.75 Million | CHF-114.51 Million | CHF108.88 Million | ▼ -9.0% |
| 2008 | -0.95x | CHF-121.95 Million | CHF-127.17 Million | CHF128.38 Million | ▼ -65.6% |
| 2007 | -0.57x | CHF-72.46 Million | CHF-78.99 Million | CHF126.34 Million | ▲ +26.5% |
| 2006 | -0.78x | CHF-70.84 Million | CHF-72.47 Million | CHF90.78 Million | ▼ -292.3% |
| 2005 | 0.41x | CHF35.58 Million | CHF34.38 Million | CHF87.69 Million | ▲ +113.5% |
| 2004 | -3.01x | CHF-63.76 Million | CHF-64.20 Million | CHF21.18 Million | ▼ -5.0% |
| 2003 | -2.87x | CHF-47.98 Million | CHF-52.42 Million | CHF16.73 Million | ▼ -74.3% |
| 2002 | -1.65x | CHF-41.35 Million | CHF-64.07 Million | CHF25.13 Million | — |